死亡捐赠者脏移植接受者与延迟移植功能之间的风险因素和结果的时代变化
Camille C Ylagan1, Paul E Schindler1, Dave B Patel1
1Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Clinical transplantation
|February 15, 2026
概括
已故捐赠者移植的延迟移植功能 (DGF) 具有不断演变的风险因素. 最近的时代显示出改善的结果,特别是减少了急性排斥,这表明对移植接受者有更好的管理策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植手术 移植手术
- 免疫学 免疫学 免疫学
背景情况:
- 延迟移植功能 (DGF) 是已故捐赠移植受体 (DDKTRs) 的重大并发症.
- 目前,没有有效的治疗药物可以预防或治疗DGF.
- 预测DGF及其相关结果依赖于捐助者和接受者因素,这些因素可能随着时间的推移而变化.
研究的目的:
- 分析DGF风险因素的时间趋势.
- 评估不同时期GDF发病率和相关结果的变化.
- 评估不断变化的医疗实践对DGF和移植成功的影响.
主要方法:
- 已故捐赠移植接受者 (DDKTRs) 根据移植年 (2000-2005,2006-2011,2012-2017,2018-2021) 被分为四个时代.
- 对DGF的风险因素,一年的移植失败 (未经审查和死亡审查),功能移植的死亡和急性排斥被按时代分析.
- 进行了统计分析,以确定时代内和跨时代的显著关联.
主要成果:
- 在四个时代中,DGF的发病率有很大差异.
- 最近的时代显示DGF持续时间较短,透析数量中位数较低.
- 循环死亡后的捐赠,更高的捐赠者肌素和更长的移植前透析是DGF风险因素,而预防性移植是保护性的.
- 与最早的时代 (E1) 相比,急性排斥风险在较后的时代 (E3和E4) 显著下降.
- 趋势表明,在最近的时代,未经审查的移植失败和功能移植的死亡风险降低了.
结论:
- 对于DGF的风险因素,随着时间的推移,它们表现出一致和不断变化的模式.
- 改进的管理策略可能有助于近年来在DGF患者中观察到急性排斥的减少.
- 最近的移植时代显示了改善移植存活率和移植后患者存活率的有希望的趋势.
相关概念视频
Kidney Transplant I: Introduction
514
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
514
Kidney Transplant II: Surgical Procedure
462
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
462
Kidney Transplant III: Nursing Management
417
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
417
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Acute Kidney Injury III: Clinical Manifestations
993
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
993


